Misuse of the Well-Stirred Model of Hepatic Drug Clearance

This publication has 13 references indexed in Scilit:

• PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM
  Drug Metabolism and Disposition, 2006
• In Vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: Varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance
  Journal of Pharmaceutical Sciences, 2006
• EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTION
  Drug Metabolism and Disposition, 2006
• Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations
  Pharmaceutical Research, 2006
• Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes
  Xenobiotica, 2005
• Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes
  European Journal of Pharmaceutical Sciences, 2004
• Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
  Clinical Pharmacology & Therapeutics, 2004
• IMPACT OF INCUBATION CONDITIONS ON BUFURALOL HUMAN CLEARANCE PREDICTIONS: ENZYME LABILITY AND NONSPECIFIC BINDING
  Drug Metabolism and Disposition, 2004
• Clearance concepts in pharmacokinetics
  Journal of Pharmacokinetics and Biopharmaceutics, 1973
• FACTORS AFFECTING DRUG METABOLISM
  Annals of the New York Academy of Sciences, 1971